LabStyle Innovations Corp. Company Profile (NASDAQ:DRIO)

Analyst Ratings

Consensus Ratings for LabStyle Innovations Corp. (NASDAQ:DRIO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.00 (172.73% upside)

Analysts' Ratings History for LabStyle Innovations Corp. (NASDAQ:DRIO)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016Rodman & RenshawReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for LabStyle Innovations Corp. (NASDAQ:DRIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/11/2016        
5/11/2016($0.38)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/17/2014($0.70)($0.25)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/18/2014($0.13)($0.16)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for LabStyle Innovations Corp. (NASDAQ:DRIO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for LabStyle Innovations Corp. (NASDAQ:DRIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for LabStyle Innovations Corp. (NASDAQ:DRIO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for LabStyle Innovations Corp. (NASDAQ:DRIO)
DateHeadline
07/28/16 07:58 AMDarioHealth is Now Direct-to-Consumer in Australia - [at noodls] - BOSTON, July 28, 2016 /PRNewswire / -- DarioHealth Corp. (NASDAQ:DRIO), a leader in digital health and mobile health solutions and the developer of the Dario Smart Diabetes Management Solution, today announced ...
07/27/16 09:22 PMLabStyle Innovations rebrands as DarioHealth
07/27/16 07:08 AMLabStyle Innovations Now DarioHealth - [at noodls] - BOSTON, July 27, 2016/PRNewswire / -- Labstyle Innovations Corp. (NASDAQ: DRIO) - a leader in digital health and mobile health solutions - announced today that it is changing its corporate name to DarioHealth ...
07/21/16 09:09 PMLabStyle Innovations Shares Jump As User Numbers For Diabetes Monitoring Product Surge
07/21/16 09:09 PMBRIEF-LabStyle Innovations executes distribution partnership with GEMCO Medical
07/21/16 03:49 PMLabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical - KAIT Jonesboro, AR - Region 8 News, weather, sports
07/21/16 07:30 AMLabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical - [PR Newswire] - LabStyle Innovations Corp. (DRIO), developer of the Dario™ Blood Glucose Monitoring System, announced today that it has signed an agreement with GEMCO Medical, an established healthcare distributor and a pioneer in the diabetes supply industry, to become the first authorized U.S. distributor of Dario. This partnership will complement LabStyle's direct-to-consumer model to further expand and strengthen its presence in the United States. LabStyle's ground-breaking, disruptive technology brings disease management into the digital age with user-centric engagement and mobile connectivity.
07/19/16 07:30 AMLabStyle Reports 100%-Plus Monthly Growth in U.S. Users Since Launch - [PR Newswire] - LabStyle Innovations (DRIO) - a leader in digital health and mobile health solutions and the developer of the Dario™ Smart Diabetes Management Solution - today announced that since the U.S. soft launch in March, the Company has seen rapid market penetration, including better than 100% growth per month in users during the second quarter. LabStyle Innovations established a direct-to-consumer business model in the U.S. to achieve a higher and faster penetration rate into this market during the launch phase.
07/11/16 07:53 AMLabStyle Innovations Joins College Diabetes Network (CDN) - [at noodls] - BOSTON, July 11, 2016/PRNewswire / -- LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced it has joined the College Diabetes Network (CDN) as a ...
06/21/16 08:22 AMWall Street Big Stock Hitters – CRDS, SBLK, LPTN, CNLI, DRIO, GLNG, TANH
05/28/16 06:55 PMLabstyle Innovations Corporation (NASDAQ:DRIO) Shorted Shares Increased 6.14% After Market Selling - HNN - Labstyle Innovations Corporation (NASDAQ:DRIO) Shorted Shares Increased 6.14% After Market SellingHNNThe stock of Labstyle Innovations Corporation (NASDAQ:DRIO) registered an increase of 6.14% in short interest. DRIO's total short interest was 60,500 shares in May as published by FINRA. Its up 6.14% from 57,000 shares, reported previously. With 26,100 ...
05/27/16 07:22 PMLabStyle Innovations to Present at Upcoming Investor Conferences - PR Newswire (press release) - LabStyle Innovations to Present at Upcoming Investor ConferencesPR Newswire (press release)LabStyle Innovations Corp. (NASDAQ: DRIO), developer of the Dario™ Diabetes Management Tool, today announced that the Company's Chief Financial Officer, Zvi Ben-David will present at the Marcum MicroCap Conference being held June 1-2 in New ...and more »
05/27/16 03:05 PMLabStyle Innovations to Present at Upcoming Investor Conferences - [PR Newswire] - During his presentations, Mr. Ben-David will discuss recent corporate and operational milestones, including the U.S. FDA Clearance and commercial launch of the Company's Dario™ Smart Diabetes Management Solution.
05/24/16 07:09 PMAnalysts Offer Insights on Healthcare Companies: Juniper Pharmaceuticals Inc. (NASDAQ: JNP), DelMar ... - Markets.co - Analysts Offer Insights on Healthcare Companies: Juniper Pharmaceuticals Inc. (NASDAQ: JNP), DelMar ...Markets.co... in the Healthcare sector as 2 experts just weighed in on Juniper Pharmaceuticals Inc. (NASDAQ: JNP), DelMar Pharmaceuticals (OTHEROTC: DMPI), Presbia PLC (NASDAQ: LENS) and LabStyle Innovations Corp. (NASDAQ: DRIO) with bullish sentimens.
05/24/16 07:09 PMLabstyle Innovations Corporation (NASDAQ:DRIO) Short Interest Increased By 5.95% - Wall Street Hints and News - Labstyle Innovations Corporation (NASDAQ:DRIO) Short Interest Increased By 5.95%Wall Street Hints and NewsThe stock of Labstyle Innovations Corporation (NASDAQ:DRIO) registered an increase of 5.95% in short interest. DRIO's total short interest was 57,000 shares in May as published by FINRA. Its up 5.95% from 53,800 shares, reported previously. With 29,200 ...
05/23/16 06:59 PMFurther Growth Projected At LabStyle Innovations - Benzinga - BenzingaFurther Growth Projected At LabStyle InnovationsBenzingaRodman & Renshaw maintains its Buy rating and $12 price target on LabStyle Innovations Corp (NASDAQ: DRIO) after the company's better-than-expected first-quarter results. LabStyle Innovations reported lower-than-projected net loss of $0.33 per share ...
05/23/16 02:33 PMFurther Growth Projected At LabStyle Innovations - Rodman & Renshaw maintains its Buy rating and $12 price target on LabStyle Innovations Corp (NASDAQ: DRIO) after the company's better-than-expected first-quarter results. LabStyle Innovations reported lower-than-projected net loss of $0.33 per share versus the brokerage's estimate of $0.38 per share. Revenues of $568,000 were also slightly above the brokerage's projection of $556,000. As a result, the brokerage has narrowed its 2016 loss per share estimate to $1.50 from $1.53. LabStyle would benefit from the uptake of its Dario Smart Meter, according to Rodman & Renshaw. LabStyle launched the Dario Diabetes Management Solution ...Full story available on Benzinga.com
05/19/16 12:40 PMLabStyle Innovations Corp. :DRIO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/16/16 12:23 PMLabstyle Innovations Corporation (NASDAQ:DRIO) Shorted Shares Increased By 5.95% - Wall Street Hints and News - Labstyle Innovations Corporation (NASDAQ:DRIO) Shorted Shares Increased By 5.95%Wall Street Hints and NewsThe stock of Labstyle Innovations Corporation (NASDAQ:DRIO) registered an increase of 5.95% in short interest. DRIO's total short interest was 57,000 shares in May as published by FINRA. Its up 5.95% from 53,800 shares, reported previously. With 29,200 ...
05/13/16 07:18 PMHealthcare ratings roundup: initiations/upgrades - Seeking Alpha - Healthcare ratings roundup: initiations/upgradesSeeking AlphaLabStyle Innovations (OTCQB:DRIO +5.4%) initiated with Buy rating and $12 (121% upside) price target by Rodman & Renshaw. Juno Therapeutics (JUNO +1.5%) initiated with an Outperform rating and $55 (48% upside) price target by Cowen & Co. WebMD ...
05/12/16 07:43 PMLabStyle Innovations Reports Q1 2016 Results - PR Newswire (press release) - LabStyle Innovations Reports Q1 2016 ResultsPR Newswire (press release)Our continued growth in revenues, and the narrowing of our gross loss and net loss provide evidence of the continued adoption of the Dario, and represent an important endorsement of our user-centric approach to diabetes management from the market ...LabStyle Reports Flat Q1 Total Loss on Stronger Revenues (NASDAQ:DRIO)Sonoran Weekly Reviewall 3 news articles »
05/11/16 06:22 AMLabStyle Innovations Reports Q1 2016 Results - [at noodls] - CAESAREA, Israel, May 11, 2016/PRNewswire / -- Quarterly gross loss narrowed 61% compared to Q4 2015 Net loss narrowed by 29% compared to Q4 2015 Launched Dario Blood Glucose Monitoring System in the United ...
05/11/16 05:05 AMLABSTYLE INNOVATIONS CORP. Files SEC form 10-Q, Quarterly Report -
05/10/16 12:17 AMRodman & Renshaw Believe LabStyle Innovations Is Driving Digital Diabetes Solutions - Rodman & Renshaw analyst Raghuram Selvaraju believes LabStyle Innovations Corp (NASDAQ: DRIO) could more than double in a year from the current levels. The brokerage initiated coverage with a rating of Buy and a price target of $12.00 on valuation.
05/09/16 06:21 AMCoverage initiated on LabStyle Innovations by Rodman & Renshaw -
05/05/16 07:00 AMLabStyle Innovations Granted Key Patent in Europe Relating to the Dario™ Diabetes Management Tool - [PR Newswire] - The Dario smart glucose monitoring device is designed to work in tandem with LabStyle's novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Tool. "This patent is a key addition to the LabStyle Innovations Intellectual Property portfolio.
05/04/16 03:04 PMLABSTYLE INNOVATIONS CORP. Files SEC form 8-K, Change in Directors or Principal Officers -
04/08/16 09:39 PMMarket News: Stock Gaps Up – EGT, MXC, OCC, EPIX, SLI, OLLI, VKTX, LEI, VRX - The company traded at $3.50 + 0.1108 (3.27 percent). LabStyle Innovations Corp (DRIO) had a gap up of 0.31 pts or 6.26 percent above its previous close of $4.95. The company traded at $5.19 + 0.243 (4.91 percent). SL Industries Inc. (SLI) had a gap up of 5 ...
03/30/16 08:00 AMmHealth Diabetes App Launches in U.S. to Transform Disease Management in World's Largest Market - [Accesswire] - Dario app sets new economic landscape for diabetes management NEW YORK, NY / ACCESSWIRE / March 30, 2016 / Americans living with diabetes can ditch their clunky traditional blood glucose meters and step ...
03/24/16 07:38 PMNasdaq : LabStyle Innovations Corp. (Nasdaq: DRIO) to Ring The Nasdaq Stock Market Closing Bell - Gal 3C/06C 95.05 degrees West18 mhz LowerDL 3811 VerticalFEC 3/4SR 13.235DR 18.295411MOD 4:2:0DVBS QPSK Social Media:For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook ...
03/23/16 07:13 PMBrussels Moment of Silence - 05AM ET - Dow Jones Business News LabStyle Innovations Corp. (Nasdaq: DRIO) to Ring The Nasdaq Stock Market Closing Bell Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use ...
03/23/16 09:27 AMLabStyle Innovations Corp. (Nasdaq: DRIO) to Ring The Nasdaq Stock Market Closing Bell - [at noodls] - ADVISORY, March 23, 2016 (GLOBE NEWSWIRE) -- What: LabStyle Innovations Corp. (Nasdaq:DRIO), developer of the Dario™ Blood Glucose Monitoring System, will visit the Nasdaq MarketSite in Times Square, in ...
03/15/16 07:00 AMLabStyle Innovations' Dario Blood Glucose Monitoring System Online e-Store and Membership Program Live in USA -
03/11/16 06:57 PMFirst NASDAQ Listings by Israeli-based Companies in 2016 - Nano Dimension Ltd. (NNDM) and LabStyle Innovations Corp. (DRIO) are the first Israeli-based companies to be listed on NASDAQ in 2016. Nano Dimension Ltd. (NNDM), a leader in the area of 3D printed electronics, uplisted its American Depositary Shares (ADSs ...
03/09/16 07:15 AMLabStyle Innovations Granted U.S. Patent Expanding IP for Fluids Testing into Industrial Applications via Mobile Devices and Apps - [PR Newswire] - The invention addresses mobile, hand held, miniature laboratory systems and testing of fluids including bodily fluids such as blood, urine, saliva, and amniotic fluid, as well as non-bodily fluids for industrial, defense and security applications including environmental and food safety. "We are very pleased to be granted our third patent in the U.S. for our platform fluids testing technology on a mobile device. This patent fortifies our IP rights around the Dario Blood Glucose Monitoring system which just launched in the U.S. for the diabetes market," said Erez Raphael, Chairman and CEO of LabStyle Innovations.
03/04/16 06:00 AMLabStyle Innovations Announces Uplisting to NASDAQ and Capital Raise of $8.5 Million - [PR Newswire] - LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today announced approval to list its common stock and warrants on the NASDAQ Capital Market effective March 4, 2016, and will trade under the symbols "DRIO" and "DRIOW", respectively. The Company also announced the pricing of a firm commitment underwritten public offering of 1,333,333 shares of common stock and warrants to purchase up to 1,333,333 shares for an approximate aggregate gross amount of $6.0 million as well as a concurrent private placement of common stock and warrants for an approximate aggregate gross amount of $2.5 million. Each share of common stock and warrant to purchase one share of common stock are offered at a combined price to the public of $4.51. The aggregate gross proceeds to LabStyle from the public offering and private placement are expected to be $8.5 million, prior to deducting underwriting discounts, commissions and other estimated offering expenses.
01/11/16 06:40 AMIdentifying Opportunity, Placing Risk -- Featured Research on Federal National Mortgage Association, GAIN Capital Holdings, Genie Energy and LabStyle Innovations - [Accesswire] - NEW YORK, NY / ACCESSWIRE / January 11, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Federal National ...

Social

About LabStyle Innovations Corp.

Labstyle Innovations Corp is an Israel-based developer of the Dario diabetes management solution. It is engaged in developing and commercializing patent-pending technology that is seeking to bring clinical laboratory testing capabilities to consumers through the use of smartphones. The Company's initial product is Dario, which is a device and software system for patient self-monitoring of blood glucose (SMBG). Dario is a patent pending system, which combines an all-in-one SMBG device consisting of a lancet to obtain a blood sample, a device-specific disposable test strip cartridge and a smartphone driven glucose reader adaptor to hold the strip and interface with the smartphone, coupled with a smartphone application and Internet-based data services. Dario will offer millions of diabetics, and in particular insulin dependent diabetics, a new option to the SMBG test kits.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DRIO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.46
  • 50 Day Moving Average: $4.72
  • 200 Day Moving Average: $4.84
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $24.50M
  • Beta: -2.36
  • Current Year EPS Consensus Estimate: $-1.5000 EPS
  • Next Year EPS Consensus Estimate: $-0.8900 EPS
Additional Links:
LabStyle Innovations Corp. (NASDAQ:DRIO) Chart for Thursday, July, 28, 2016